IDEX Biometrics (IDEX) Q4 2024 earnings summary

Executive summary

• Achieved Mastercard and Visa certification for IDEX Pay platform, enabling global biometric card launches and new market entry in Japan with LIFECARD, launch planned for H1 2025.

• Reached scale manufacturing quality with key partners; KONA I became first Mastercard-certified manufacturer for both PVC and metal biometric cards.

• Completed rights issue in November, broadening retail investor participation and strengthening capital base.

• Streamlined operations, reduced workforce, and closed most activities in China and US subsidiaries.

Financial highlights

• No product revenue in Q4 2024; total revenue $24k, down from $484k in Q4 2023 due to lower sensor shipments.

• Net loss for Q4 2024 was $2.1 million; adjusted net loss was $4.6 million.

• Operating expenses (excluding cost of products sold and bad debt) were $2.4 million, below target.

• Non-cash goodwill impairment of $1.0 million recorded in Q4 2024.

• Cash balance at December 31, 2024, was $2.0 million, down from $11.4 million a year earlier.

Outlook and guidance

• Biometric smart card market expected to reach 37 million cards by 2028; IDEX aims to capture significant share.

• LIFE CARD commercial deployment in Japan targeted for H1 2025; India market pending regulatory approval.

• Three access products in commercial ramp-up, with launches planned in Q1 and Q3 2025.

• Confident in long-term growth driven by biometric card adoption for multifactor authentication.

• Market launches delayed in some regions due to political instability, but pipeline remains strong.